1) USFDA amends emergency use authorization for Sotrovimab due to Omicron BA.2 Subvariant
2) Novaris gets USFDA nod for Pulvicto to treat prostate cancer
Hello, and thank you for visiting the AIKTC-KRRC News Page. If you have any questions regarding the AIKTC-KRRC, please comment below, find us at facebook.com/AIKTCCentralLibrary/, or contact us at 022-27481247/48, or librarian@aiktc.ac.in